Literature DB >> 15784796

Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls.

Andreas H Böhmelt1, Urs M Nater, Saskia Franke, Dirk H Hellhammer, Ulrike Ehlert.   

Abstract

OBJECTIVE: The aim of this study was to investigate alterations of pituitary-adrenal activity under both stimulated and unstimulated conditions in patients with functional gastrointestinal disorders.
METHODS: Thirty subjects who fulfilled the Rome Diagnostic Criteria for either irritable bowel syndrome or nonulcer dyspepsia and 24 healthy controls took part in the study. Free salivary morning cortisol and diurnal cortisol profiles were obtained for all subjects. On a second day, a low-dose dexamethasone suppression test was applied. Additionally, in all subjects a corticotropin-releasing hormone (CRH) challenge test was performed.
RESULTS: The results show attenuated unstimulated cortisol levels in patients compared with controls. After CRH challenge, blunted adrenocorticotropic hormone and cortisol responses were observed. These findings suggest lower pituitary and adrenocortical activity in patients with functional gastrointestinal disorders.
CONCLUSION: The observed pituitary-adrenal reactivity in these patients is discussed as a possible consequence of lower adrenocortical activity, possibly resulting in a disinhibition of CRH in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784796     DOI: 10.1097/01.psy.0000157064.72831.ba

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  32 in total

Review 1.  Developmental influences on medically unexplained symptoms.

Authors:  C A Tony Buffington
Journal:  Psychother Psychosom       Date:  2009-03-09       Impact factor: 17.659

2.  Effect of day-to-day variations in adrenal cortex hormone levels on abdominal symptoms.

Authors:  Nagisa Sugaya; Shuhei Izawa; Namiko Ogawa; Kentaro Shirotsuki; Hitomi Kobayashi; Kosuke C Yamada; Hideki Tsumura; Shinobu Nomura; Hironori Shimada
Journal:  Biopsychosoc Med       Date:  2010-03-18

3.  Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.

Authors:  Maria M Buckley; Ken D O'Halloran; Mark G Rae; Timothy G Dinan; Dervla O'Malley
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

Review 4.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

Review 5.  What goes around comes around: novel pharmacological targets in the gut-brain axis.

Authors:  Camila González-Arancibia; Jorge Escobar-Luna; Camila Barrera-Bugueño; Camilo Díaz-Zepeda; María P González-Toro; Loreto Olavarría-Ramírez; Francesca Zanelli-Massai; Martin Gotteland; Javier A Bravo; Marcela Julio-Pieper
Journal:  Therap Adv Gastroenterol       Date:  2016-02-17       Impact factor: 4.409

6.  Effect of self-management intervention on cortisol and daily stress levels in irritable bowel syndrome.

Authors:  Wimon Deechakawan; Kevin C Cain; Monica E Jarrett; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2011-07-15       Impact factor: 2.522

7.  Depression and anxiety correlate differently with salivary free cortisol in the morning in patients with functional somatic syndrome.

Authors:  Hiromi Mutsuura; Kenji Kanbara; Mikihiko Fukunaga; Kazumi Yamamoto; Ikumi Ban; Kana Kitamura; Yoshihide Nakai
Journal:  Appl Psychophysiol Biofeedback       Date:  2009-08-07

8.  Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.

Authors:  Cristina Stasi; Massimo Bellini; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Mariano Grosso; Emiliano Duranti; Maria Rosaria Metelli; Dario Gambaccini; Lea Bianchi; Gian Luca Di Tanna; Giacomo Laffi; Stefano Taddei; Santino Marchi
Journal:  Int J Colorectal Dis       Date:  2013-02-02       Impact factor: 2.571

9.  Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome.

Authors:  R L Burr; M E Jarrett; K C Cain; S-E Jun; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2009-07-01       Impact factor: 3.598

10.  Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.

Authors:  L Chang; S Sundaresh; J Elliott; P A Anton; P Baldi; A Licudine; M Mayer; T Vuong; M Hirano; B D Naliboff; V Z Ameen; E A Mayer
Journal:  Neurogastroenterol Motil       Date:  2008-08-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.